BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30995111)

  • 1. Gene deletion of the Na
    Nespoux J; Patel R; Hudkins KL; Huang W; Freeman B; Kim YC; Koepsell H; Alpers CE; Vallon V
    Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1201-F1210. PubMed ID: 30995111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene knockout of the Na
    Nespoux J; Patel R; Zhang H; Huang W; Freeman B; Sanders PW; Kim YC; Vallon V
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1100-F1112. PubMed ID: 32116018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockout of Na
    Song P; Huang W; Onishi A; Patel R; Kim YC; van Ginkel C; Fu Y; Freeman B; Koepsell H; Thomson S; Liu R; Vallon V
    Am J Physiol Renal Physiol; 2019 Jul; 317(1):F207-F217. PubMed ID: 31091127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of renal tubule-specific knockdown of the Na
    Onishi A; Fu Y; Darshi M; Crespo-Masip M; Huang W; Song P; Patel R; Kim YC; Nespoux J; Freeman B; Soleimani M; Thomson S; Sharma K; Vallon V
    Am J Physiol Renal Physiol; 2019 Aug; 317(2):F419-F434. PubMed ID: 31166707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1.
    Novikov A; Fu Y; Huang W; Freeman B; Patel R; van Ginkel C; Koepsell H; Busslinger M; Onishi A; Nespoux J; Vallon V
    Am J Physiol Renal Physiol; 2019 Jan; 316(1):F173-F185. PubMed ID: 30427222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia.
    Rieg T; Masuda T; Gerasimova M; Mayoux E; Platt K; Powell DR; Thomson SC; Koepsell H; Vallon V
    Am J Physiol Renal Physiol; 2014 Jan; 306(2):F188-93. PubMed ID: 24226519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus.
    Vallon V; Rose M; Gerasimova M; Satriano J; Platt KA; Koepsell H; Cunard R; Sharma K; Thomson SC; Rieg T
    Am J Physiol Renal Physiol; 2013 Jan; 304(2):F156-67. PubMed ID: 23152292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organic anion transporter OAT3 enhances the glucosuric effect of the SGLT2 inhibitor empagliflozin.
    Fu Y; Breljak D; Onishi A; Batz F; Patel R; Huang W; Song P; Freeman B; Mayoux E; Koepsell H; Anzai N; Nigam SK; Sabolic I; Vallon V
    Am J Physiol Renal Physiol; 2018 Aug; 315(2):F386-F394. PubMed ID: 29412698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor-dependent pathway after renal injury in mice.
    Zhang Y; Nakano D; Guan Y; Hitomi H; Uemura A; Masaki T; Kobara H; Sugaya T; Nishiyama A
    Kidney Int; 2018 Sep; 94(3):524-535. PubMed ID: 30045814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased abundance of major Na(+) transporters in kidneys of rats with ischemia-induced acute renal failure.
    Kwon TH; Frøkiaer J; Han JS; Knepper MA; Nielsen S
    Am J Physiol Renal Physiol; 2000 Jun; 278(6):F925-39. PubMed ID: 10836980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tubular hypothesis of nephron filtration and diabetic kidney disease.
    Vallon V; Thomson SC
    Nat Rev Nephrol; 2020 Jun; 16(6):317-336. PubMed ID: 32152499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for tubular Na
    Onishi A; Fu Y; Patel R; Darshi M; Crespo-Masip M; Huang W; Song P; Freeman B; Kim YC; Soleimani M; Sharma K; Thomson SC; Vallon V
    Am J Physiol Renal Physiol; 2020 Oct; 319(4):F712-F728. PubMed ID: 32893663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of NHE3 and SGLT1 by the circadian clock protein Per1 in proximal tubule cells.
    Solocinski K; Richards J; All S; Cheng KY; Khundmiri SJ; Gumz ML
    Am J Physiol Renal Physiol; 2015 Dec; 309(11):F933-42. PubMed ID: 26377793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-17-92 ameliorates renal ischemia reperfusion injury.
    Song T; Chen M; Rao Z; Qiu Y; Liu J; Jiang Y; Huang Z; Wang X; Lin T
    Kaohsiung J Med Sci; 2018 May; 34(5):263-273. PubMed ID: 29699633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury.
    Chen J; Chen JK; Harris RC
    Kidney Int; 2012 Jul; 82(1):45-52. PubMed ID: 22418982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SGLT2 mediates glucose reabsorption in the early proximal tubule.
    Vallon V; Platt KA; Cunard R; Schroth J; Whaley J; Thomson SC; Koepsell H; Rieg T
    J Am Soc Nephrol; 2011 Jan; 22(1):104-12. PubMed ID: 20616166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice.
    Vallon V; Gerasimova M; Rose MA; Masuda T; Satriano J; Mayoux E; Koepsell H; Thomson SC; Rieg T
    Am J Physiol Renal Physiol; 2014 Jan; 306(2):F194-204. PubMed ID: 24226524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in expression of sodium cotransporters and aquaporin-2 during ischemia-reperfusion injury in rabbit kidney.
    Jung JS; Lee RH; Koh SH; Kim YK
    Ren Fail; 2000; 22(4):407-21. PubMed ID: 10901179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIF-2/D-DT enhances proximal tubular cell regeneration through SLPI- and ATF4-dependent mechanisms.
    Ochi A; Chen D; Schulte W; Leng L; Moeckel N; Piecychna M; Averdunk L; Stoppe C; Bucala R; Moeckel G
    Am J Physiol Renal Physiol; 2017 Sep; 313(3):F767-F780. PubMed ID: 28539339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac ischemia-reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity.
    Yoshii A; Nagoshi T; Kashiwagi Y; Kimura H; Tanaka Y; Oi Y; Ito K; Yoshino T; Tanaka TD; Yoshimura M
    Cardiovasc Diabetol; 2019 Jul; 18(1):85. PubMed ID: 31262297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.